Drug Type Small molecule drug |
Synonyms E 2082 |
Target |
Action antagonists |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epilepsy, Reflex | Phase 2 | United States | 31 Oct 2018 |
Phase 2 | 8 | placebo+E2082 (Treatment A: Placebo) | ffyyzlboal(henuhuaaiy) = suadbixjpe bammnhtfjv (nddnnqreau, 4.604) View more | - | 28 Sep 2020 | ||
(Treatment B: E2082 2.5 mg) | ffyyzlboal(henuhuaaiy) = djpmtmqzus bammnhtfjv (nddnnqreau, 4.336) View more |





